Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection

We report a case of gynaecomastia developed in a HIV-seropositive man, associated with a severe lipodystrophy. We hypothesize the responsibility of stavudine and didanosine in the development of these 2 complications. If many reports suggest that the protease inhibitors may promote gynaecomastia, lo...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of STD & AIDS Vol. 12; no. 7; p. 481
Main Authors:	Aquilina, C, Viraben, R
Format:	Journal Article
Language:	English
Published:	England 01-07-2001
Subjects:	Adult Anti-HIV Agents - adverse effects Didanosine - adverse effects Gynecomastia - chemically induced HIV Infections - complications HIV Infections - drug therapy HIV Seropositivity - complications HIV Seropositivity - drug therapy Humans Lipodystrophy - chemically induced Male Stavudine - adverse effects
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We report a case of gynaecomastia developed in a HIV-seropositive man, associated with a severe lipodystrophy. We hypothesize the responsibility of stavudine and didanosine in the development of these 2 complications. If many reports suggest that the protease inhibitors may promote gynaecomastia, long-term nucleoside analogue therapy may also cause this side effect.
ISSN:	0956-4624
DOI:	10.1258/0956462011923390